Recent Updates
Recently added Catalysts
ABBV Positive Sentiment Score: 60/100

AbbVie to Present at the Bank of America Securities Healthcare Conference AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025. Management will participate...

Key Takeaway: AbbVie (NYSE: ABBV) is set to participate in the Bank of America Securities Healthcare Conference on May 14, 2025. Management will engage in a fireside chat at 12:00 p.m. Central time, which will also be available via a live audio webcast. This presents an opportunity for investors and stakeholders to understand AbbVie's ongoing efforts in addressing healthcare challenges through innovative medicine.

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie is engaging with investors at a prominent healthcare conference.
  • The company aims to address significant health issues through innovative solutions.
  • There will be a live audio webcast of the session, increasing accessibility for stakeholders.

Full Press Release Details

NORTH CHICAGO, Ill. , May 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV ) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025 . Management will participate in a fireside chat at 12:00 p.m. Central time .
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com . An archived edition of the session will be available later that day.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X (formerly Twitter) , and YouTube.
Media: Gabby Tarbert (224) 244-0111 Investors: Liz Shea (847) 935-2211
[email protected] [email protected]

21 %

Frequently Asked Questions

When is AbbVie's participation in the conference?

AbbVie will participate in the conference on May 14, 2025, at 12:00 p.m. CT.

How can I access the live webcast of AbbVie's presentation?

The live audio webcast can be accessed via AbbVie's Investor Relations website.

What will be available after the live session?

An archived version of the session will be available later on the same day.

What are AbbVie's main therapeutic focus areas?

AbbVie focuses on immunology, oncology, neuroscience, and eye care.

Where can I find more information about AbbVie?

More information can be found on AbbVie's official website, www.abbvie.com.

Last updated: May 6, 2025